Bayer Stock Slumps After Firm Ordered To Pay More Than $2B in Latest Roundup Case

  • Home
  • Information
  • Mar 24, 2025
Bayer Stock Slumps After Firm Ordered To Pay More Than $2B in Latest Roundup Case


Key Takeaway



Bayer was ordered to pay more than $2 billion by a jury in a Georgia state court in the latest legal case surrounding alleged cancer risk tied to its Roundup weed killer, sending shares of the German pharmaceutical drug giant down Monday.

The verdict reached Friday by a jury in a trial in the State Court of Cobb County, Georgia, included $2 billion in punitive damages and $65 million in compensatory damages , a Bayer spokesman confirmed.

Shares of the pharmaceuticals and crop science conglomerate fell over 6% in German trading Monday.

Part of Roundup Legal Cases Inherited From Monsanto

Bayer has been dealing with a slew of U.S. legal cases after its takeover of Roundup weed killer manufacturer Monsanto.

The company said it disagreed with the jury's verdict, "as it conflicts with the overwhelming weight of scientific evidence and the consensus of regulatory bodies and their scientific assessments worldwide."

“We believe that we have strong arguments on appeal to get this verdict overturned and the excessive and unconstitutional damage awards eliminated or reduced," Bayer added.

The company said damages in Roundup-related cases that reached final judgments were cut by 90% versus original jury awards.

Read the original article on Investopedia